News for the Pharmaceutical Industry
WXpress is a newsletter from WuXi AppTec informing clients of new programs, services and successes with our Pharmaceutical Services.
WuXi AppTec’s Pharmaceutical Services, often referred to as Small Molecule Services, are based in China and span the entire research and development platform, including the design and synthesis of molecules, as well as supporting functions such as structural biology & modeling, computational & medicinal chemistry, and analytical services.
Small and large molecule companies alike benefit from WuXi’s laboratory services dedicated to discovery biology & pharmacology, ADME/DMPK, bioanalytical, and preclinical development. In addition, WuXi offers a full spectrum of development and manufacturing services for pharmaceuticals.
WuXi AppTec sends the WXpress newsletter to subscribers in the pharmaceutical industry. Please find past issues below:
If you are not currently receiving the newsletter and would like to be on our mailing list, please email us at: firstname.lastname@example.org.